CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. announced today that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been ...

The name change, effective Jan. 1, has been underway since 2022, as Allscripts worked to move its products to the new brand, according to a Jan. 3 press release from the company. All remaining ...

What looks to be a small wine fridge is tucked away inconspicuously in the corner of Veradigm’s 12th floor office in the Flatiron neighborhood of Manhattan. But rather than bottles of burgundy, the ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.

Veradigm, Allscripts’ payer and life sciences division, joined Boston-based Harvard Pilgrim Health Care Institute and other collaborators to continue developing the FDA’s drug safety database. The FDA ...

UPDATE: Sept. 25, 2023: Veradigm has received notice that its shares will be delisted from the Nasdaq after the health IT company failed to file required financial paperwork before the end of the ...

Over at the former Allscripts, ailing Veradigm reported a strong cash position this week, and sale rumors immediately flourished, while another electronic health record vendor, Meditech, announced ...

SOUTH SAN FRANCISCO and CHICAGO, Oct. 6, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), a major provider of drug knowledge that helps healthcare professionals make precise decisions, and Veradigm ...

After shedding its hospital business segment earlier this year, health IT company Allscripts is doubling down on its strategy to grow its payers and life sciences businesses. Allscripts sold its ...